Nasdaq Edges Lower; Gold Rises 1.5%

U.S. stocks traded mixed midway through trading, with the S&P 500 and the Nasdaq Composite moving lower on Tuesday.

The Dow traded up 0.12% to 32,797.11 while the NASDAQ fell 0.23% to 10,521.67. The S&P 500 also fell, dropping, 0.05% to 3,815.93.

Also check this: CNN Fear & Greed Index Moves To 'Fear' Zone Amid Recession Concerns

Leading and Lagging Sectors

Energy shares rose by 1.4% on Tuesday. Meanwhile, top gainers in the sector included Nine Energy Service, Inc. NINE, up 8%, and Uranium Energy Corp. UEC, up 8%.

In trading on Tuesday, consumer discretionary shares tumbled by 1.1%.

Top Headline


Housing starts in the US fell 0.5% to an annualized rate of 1.427 million in November, while building permits dipped 11.2 percent from a month ago to an annual rate of 1.342 million in November.


Equities Trading UP


  • Verona Pharma plc (NASDAQ: VRNA) shares shot up 33% to $17.96 after the company announced ensifentrine met primary and key secondary endpoints in the Phase 3 ENHANCE-1 trial for COPD.
  • Shares of IceCure Medical Ltd ICCM got a boost, shooting 322% to $3.95 after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who cannot be offered kidney-preserving surgery.
  • Athenex, Inc. ATNX shares were also up, gaining 39% to $0.1880 after the company announced Quantum Leap Healthcare Collaborative reported a trial result of I-SPY2 trial for oral paclitaxel in combination with PD-1 and carboplatin in neoadjuvant breast cancer.


Equities Trading DOWN

  • Magenta Therapeutics, Inc. (NASDAQ: MGTA) shares tumbled 47% to $0.4413 after the company reported it stopped dosing participants at the Cohort 4 dosing level and plans to dose additional participants at the Cohort 3 dosing level due to dose-limiting toxicities.
  • Shares of Arcus Biosciences, Inc. RCUS were down 30% to $21.24. Gilead Sciences and Arcus Biosciences announced results from the fourth interim analysis of the ARC-7 Phase 2 study for metastatic non-small cell lung cancer with PD-L1 tumor proportion score ≥50% without epidermal growth factor receptor or anaplastic lymphoma kinase mutations.
  • Entrada Therapeutics, Inc. TRDA was down, falling 27% to $14.60 after the company said it received a clinical hold notice from the FDA regarding its Investigational New Drug Application for ENTR-601-44 for the potential treatment of Duchenne muscular dystrophy.

Also check out: Wall Street Drops for Fourth Straight Session, Volatility In Markets Eases Further


In commodity news, oil traded up 0.7% to $75.69 while gold traded up 1.5% at $1,825.30.

Silver traded up 4.5% to $24.24 on Tuesday while copper rose 0.6% to $3.8070.


Euro zone

European shares were mixed today. The eurozone’s STOXX 600 fell 0.15%, London’s FTSE 100 rose 0.3% while Spain’s IBEX 35 Index rose 0.96%. The German DAX fell 0.31%, French CAC 40 fell 0.18% and Italy’s FTSE MIB Index gained 0.23%.

The Eurozone recorded a current account deficit of EUR 4.4 billion in October versus a year-ago surplus of EUR 6.51 billion. Italy’s current account surplus shrank to EUR 710 million in October from EUR 3,024 million in the year-ago month.

The annual producer inflation in Germany declined to 28.2% in November from 34.5% in the previous month.


Asia Pacific Markets

Asian markets closed lower on Tuesday, with the Japan’s Nikkei dropping 2.46% and Hong Kong’s Hang Seng Index declining 1.33%. China’s Shanghai Composite Index fell 1.07%.

The annual inflation rate in Hong Kong came in at 1.8% in November, the same as in the earlier month. The Bank of Japan kept its key short-term interest rate unchanged at -0.1%.



Housing starts in the US fell 0.5% to an annualized rate of 1.427 million in November, while building permits dipped 11.2 percent from a month ago to an annual rate of 1.342 million in November.

Check out this: $7.5 Million Bet On This Financial Services Stock? Check Out These 3 Stocks Insiders Are Buying

COVID-19 Update

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 101,825,070 cases with around 1,113,300 deaths. India confirmed a total of at least 44,677,340 cases and 530,670 deaths, while France reported over 38,899,900 COVID-19 cases with 160,610 deaths. In total, there were at least 658,535,310 cases of COVID-19 worldwide with more than 6,674,360 deaths.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsPenny StocksEurozoneCommoditiesSmall CapGlobalIntraday UpdateMarketsTrading IdeasMid-Day Market Update
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!